These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22792269)

  • 1. The role of Dlc1 isoform 2 in K-Ras2(G12D) induced thymic cancer.
    Sabbir MG; Prieditis H; Ravinsky E; Mowat MR
    PLoS One; 2012; 7(7):e40302. PubMed ID: 22792269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of Dlc1 isoforms in the mouse and study of the biological function of a single gene trapped isoform.
    Sabbir MG; Wigle N; Loewen S; Gu Y; Buse C; Hicks GG; Mowat MR
    BMC Biol; 2010 Mar; 8():17. PubMed ID: 20199662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
    Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
    J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.
    Basak P; Dillon R; Leslie H; Raouf A; Mowat MR
    BMC Cancer; 2015 Sep; 15():630. PubMed ID: 26353792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel isoform of the 8p22 tumor suppressor gene DLC1 suppresses tumor growth and is frequently silenced in multiple common tumors.
    Low JS; Tao Q; Ng KM; Goh HK; Shu XS; Woo WL; Ambinder RF; Srivastava G; Shamay M; Chan AT; Popescu NC; Hsieh WS
    Oncogene; 2011 Apr; 30(16):1923-35. PubMed ID: 21217778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory effects of deleted in liver cancer 1 gene on gallbladder cancer growth through induction of cell cycle arrest and apoptosis.
    Qin Y; Chu B; Gong W; Wang J; Tang Z; Shen J; Quan Z
    J Gastroenterol Hepatol; 2014 May; 29(5):964-72. PubMed ID: 24329682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRL4A-FBXW5-mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth.
    Kim TY; Jackson S; Xiong Y; Whitsett TG; Lobello JR; Weiss GJ; Tran NL; Bang YJ; Der CJ
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16868-73. PubMed ID: 24082123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DLC1 is the principal biologically-relevant down-regulated DLC family member in several cancers.
    Wang D; Qian X; Rajaram M; Durkin ME; Lowy DR
    Oncotarget; 2016 Jul; 7(29):45144-45157. PubMed ID: 27174913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deleted in liver cancer 1 (DLC1) negatively regulates Rho/ROCK/MLC pathway in hepatocellular carcinoma.
    Wong CC; Wong CM; Ko FC; Chan LK; Ching YP; Yam JW; Ng IO
    PLoS One; 2008 Jul; 3(7):e2779. PubMed ID: 18648664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.
    Du X; Qian X; Papageorge A; Schetter AJ; Vass WC; Liu X; Braverman R; Robles AI; Lowy DR
    Cancer Res; 2012 Sep; 72(17):4405-16. PubMed ID: 22693251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PKA-induced dimerization of the RhoGAP DLC1 promotes its inhibition of tumorigenesis and metastasis.
    Ko FC; Chan LK; Sze KM; Yeung YS; Tse EY; Lu P; Yu MH; Ng IO; Yam JW
    Nat Commun; 2013; 4():1618. PubMed ID: 23511482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DLC1 tumor suppressor gene inhibits migration and invasion of multiple myeloma cells through RhoA GTPase pathway.
    Ullmannova-Benson V; Guan M; Zhou X; Tripathi V; Yang XY; Zimonjic DB; Popescu NC
    Leukemia; 2009 Feb; 23(2):383-90. PubMed ID: 18923442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the activity of deleted in liver cancer 1 (DLC1) by tensins controls cell migration and transformation.
    Cao X; Voss C; Zhao B; Kaneko T; Li SS
    Proc Natl Acad Sci U S A; 2012 Jan; 109(5):1455-60. PubMed ID: 22307599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines.
    Ullmannova V; Popescu NC
    Cancer Detect Prev; 2007; 31(2):110-8. PubMed ID: 17418982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H2O2 inhibits proliferation and mediates suppression of migration via DLC1/RhoA signaling in cancer cells.
    Ma L; Zhu WZ; Liu TT; Fu HL; Liu ZJ; Yang BW; Song TY; Li GR
    Asian Pac J Cancer Prev; 2015; 16(4):1637-42. PubMed ID: 25743845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of DLC1 in endothelial cells compromises the angiogenesis process.
    Shih YP; Yuan SY; Lo SH
    Cancer Lett; 2017 Jul; 398():46-51. PubMed ID: 28408355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor tyrosine kinase activation of RhoA is mediated by AKT phosphorylation of DLC1.
    Tripathi BK; Grant T; Qian X; Zhou M; Mertins P; Wang D; Papageorge AG; Tarasov SG; Hunter KW; Carr SA; Lowy DR
    J Cell Biol; 2017 Dec; 216(12):4255-4270. PubMed ID: 29114068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer.
    Qian X; Durkin ME; Wang D; Tripathi BK; Olson L; Yang XY; Vass WC; Popescu NC; Lowy DR
    Cancer Res; 2012 Nov; 72(22):5900-11. PubMed ID: 23010077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleted in liver cancer 2 (DLC2) suppresses cell transformation by means of inhibition of RhoA activity.
    Leung TH; Ching YP; Yam JW; Wong CM; Yau TO; Jin DY; Ng IO
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15207-12. PubMed ID: 16217026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter methylation of the DLC‑1 gene and its inhibitory effect on human colon cancer.
    Dai Z; Jin Y
    Oncol Rep; 2013 Sep; 30(3):1511-7. PubMed ID: 23783552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.